Inpharma Weekly

, Volume 1625, Issue 1, pp 21–21 | Cite as

Certolizumab pegol: BLA accepted for filing and review

Media release
  • 5 Downloads

Keywords

Rheumatoid Arthritis Arthritis Tumour Necrosis Tumour Necrosis Factor Medium Release 

Copyright information

© Adis International Ltd 2008

Personalised recommendations